✦ LIBER ✦

Estimating clinical and economic burden of pneumococcal meningitis in Malaysia using Casemix data

✍ Scribed by Namaitijiang Maimaiti, A Zafar, M Amrizal, Md Isa Zaleha…

Book ID: 120683489
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 77 KB
Volume: 12
Category: Article
ISSN: 1472-6963
DOI: 10.1186/1472-6963-12-S1-O4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and economic burden of pneumoco

Clinical and economic burden of pneumococcal disease in older US adults

✍ Derek Weycker; David Strutton; John Edelsberg; Reiko Sato; Lisa A. Jackson 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Clinical and economic burden of invasive

Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based study

✍ Joon Young Song, Jun Yong Choi, Jin Soo Lee, In-Gyu Bae… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 217 KB

PIN86 Clinical and Economic Burden of Co

PIN86 Clinical and Economic Burden of Community Acquired Pneumonia in 7 Countries. A Comparison With Invasive Pneumococcal Disease

✍ E. Delgleize; O. Topachevskyi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

IN1 ECONOMIC AND CLINICAL BURDEN OF PNEU

IN1 ECONOMIC AND CLINICAL BURDEN OF PNEUMOCOCCAL DISEASES AND ACUTE OTITIS MEDIA IN TAIWAN: A NATIONWIDE POPULATION-BASED DATABASE ANALYSIS

✍ Chang, CJ; Wang, PC; Huang, YC; Wu, BS 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PMH16 Analysis of the Economic Burden an

PMH16 Analysis of the Economic Burden and Cost Structure of Schizophrenia in Germany Using Observational Sickness Fund Data

✍ S. Frey; R. Linder; T. Stargardt 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Using covariates to reduce uncertainty i

Using covariates to reduce uncertainty in the economic evaluation of clinical trial data

✍ F. J. Vázquez-Polo; M. A. Negrín Hernández; B. González López-Valcárcel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

## Abstract As part of their practice, policymakers have to make economic evaluations using clinical trial data. Recent interest has been expressed in determining how cost‐effectiveness analysis can be undertaken in a regression framework. In this respect, published research basically provides a ge